Navigation Links
Summit VetPharm has Identified Two Instances of Diverted Vectra 3D(TM)
Date:2/4/2008

echnology and our legally-binding anti-diversion agreement, which must be signed by the practice owner prior to a purchase of Vectra 3D, we can keep companion animal health exactly where it belongs -- in the hands of professionals. The terms strictly prohibit the sale of Vectra 3D outside of the veterinary client patient relationship. This agreement explicitly states that sales outside of this relationship will result in legal action against both the identified veterinary diverter as well as any potential reseller of the product. Veterinarian response to the Summit VetPharm anti-diversion policy and the proprietary Bloodhound technology has been overwhelmingly positive," continued Julia Stephanus.

Vectra 3D's new triple-action topical ectoparasiticide formula is available to pet owners only through licensed veterinarians. Vectra 3D is available in four different sizes: for dogs and puppies over 7 weeks of age weighing 2.5 to 20 pounds; 21 to 55 pounds; 56 to 95 pounds, and for dogs over 95 pounds. Vectra 3D is currently available to veterinarians from the following distributors: NLS Animal Health, a division of Henry Schein Inc, Midwest Veterinary Supply, Inc., Merritt Veterinary Supplies, Inc., Associated Medical, Great Western, Northeast Veterinary Supply Company, Victor Medical Company and Sanum Puerto Rico, Inc.

Media Contact: Dr. Albert H. Ahn, Summit VetPharm, 201-242-8409

Summit VetPharm, LLC

Founded by veterinarians and experienced industry professionals, Summit VetPharm is committed to protecting the health and welfare of both companion animals and companion animal veterinary practices. As a wholly-owned subsidiary of the Sumitomo Corporation and part of the Sumitomo Corporation group of companies, Summit VetPharm is backed by a longstanding reputation for values and ethics in business and is dedicated to raising the standards in animal health. Summit VetPharm is headquartered in Fort Lee, New Jersey, USA . For more information,
'/>"/>

SOURCE Summit VetPharm, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
2. Novel Mechanism for Long-Term Learning Identified by Carnegie Mellon Researchers
3. Brain Signature for Cigarette Cravings Identified
4. New Risk Factor for Heart Disease Identified in Very Young Children, According to Study at American Heart Association Scientific Sessions
5. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
6. Potential Early Warning System for Lung Cancer Identified
7. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Endoscopy Identified as Safe and Effective Method in Treating Common Complication of Gastric Bypass Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014   Auxilium ... a specialty biopharmaceutical company, today announced positive results ... collagenase clostridium histolyticum (or CCH) for the treatment ... cellulite. In the Phase 2a trial, all three ... high (0.84mg)) showed an improvement in the appearance ...
(Date:8/20/2014)... Md. , Aug. 20, 2014  The ... lauded the latest results achieved by the real-time, ... as the National Precursor Log Exchange (NPLEx), automatically ... officials track down methamphetamine offenders and make arrests. ... Missouri blocked the sale ...
(Date:8/20/2014)... YORK , Aug. 20, 2014 /PRNewswire/ ... research report is available in its catalogue: ... in France, Key Trends and Opportunities to ... Synopsis The report provides in ... the French personal accident and health insurance ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 2Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 3Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 4Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 5Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 6Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 7Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 8Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 9Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 10Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 11Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 12Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 13Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 14Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 15Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 16Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 17Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 18Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 19Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 20Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 21Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 22Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 23
(Date:8/21/2014)... Albany, New York (PRWEB) August 21, 2014 ... Transparency Market Research "Medical Fiber Optics Market-Global Industry Analysis, ... the global medical fiber optics market was valued at ... grow at a CAGR of 7.6% from 2013 to ... million in 2019. , The medical fiber optics market ...
(Date:8/21/2014)... According to a new market report published by ... Analysis, Size, Share, Growth, Trends and Forecast, 2012 - ... USD 236.1 million in 2011 and is estimated to ... at a CAGR of 6.3% from 2012 to 2018. ... http://www.transparencymarketresearch.com/fundus-cameras.html . , Fundus cameras market growth in recent ...
(Date:8/21/2014)... 21, 2014 The worlds of personal ... an exciting chance to grab free products. BaliniSports ... from Tom's of Maine with all qualifying purchases for ... our environmentally friendly yoga apparel is simply perfect,” said ... promotion between the two brands is intended to give ...
(Date:8/21/2014)... August 21, 2014 Tibet has long ... the mysterious mountaintop kingdom. Prayers flags whip in ... and the low rumble of chanting monks fill the ... of the world’, access to Tibet is challenging due ... foreign land can prove to be daunting for even ...
(Date:8/21/2014)... David Mullings’ new book, Things #Entrepreneurs ... collection of quotes from famous entrepreneurs to the not ... entrepreneurs on their challenging paths towards success. Earth Source ... of President and Founder Audrey Darrow alongside the bits ... celebrities such as Oprah Winfrey, Steve Jobs, and Richard ...
Breaking Medicine News(10 mins):Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 3Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 4Health News:Fundus Cameras Market: Product Type- Mydriatic, Non-Mydriatic, Hybrid and ROP Cameras; End Users- Hospitals, Ophthalmology Clinics and Ophthalmic & Optometrist Offices 2Health News:Tom's of Maine Partner up with BaliniSports Yoga Apparel 2Health News:Earth Source Organics President Audrey Darrow Featured in New David Mullings Book 2
... BLU-MED Response Systems,announced today two new contract ... preparedness and surge capacity for hospitals and,public health ... District,Four and Suffolk County, NY., The first ... awarded by the Idaho Central District Health Department. ...
... of connecting with doctors in real time, speeding care, study ... patients report to doctors on their symptoms and side effects ... Even the sickest cancer patients are willing and capable of ... Cancer Center in New York City. , "Cancer care has ...
... Calif., Nov. 30 Omnicell, Inc.,(Nasdaq: OMCL ... acute healthcare,facilities, today announced that it has entered ... in an all cash transaction valued at,approximately $26 ... mobile cart technology that brings quality healthcare to ...
... a significantly slower rate of decline in lung function in ... study. , Researchers found that patients with cystic fibrosis ... percent reduction in loss of lung function compared to those ... a period of two to seven years. , It ...
... Specifically for Resource-Limited ... Global Procurement Consortium, UPPSALA, Sweden, November 30 ... an agreement with the Clinton,Foundation HIV/AIDS Initiative (CHAI). Under ... to members of CHAI,s,Procurement Consortium at a discounted price. ...
... AstraZeneca (NYSE:,AZN) today announced that the United States ... six-month period of,exclusivity to market ARIMIDEX(R) (anastrozole) for its ... exclusivity being,granted by the FDA, the patent was due ... approved in the US for the for the following,indications:, ...
Cached Medicine News:Health News:BLU-MED Announces New Medical Preparedness Contracts 2Health News:Cancer Patients Gain From Reporting Symptoms Online 2Health News:Omnicell Announces Agreement to Acquire Rioux Vision, Inc. 2Health News:Omnicell Announces Agreement to Acquire Rioux Vision, Inc. 3Health News:Ibuprofen associated with slower lung function decline in children with cystic fibrosis 2Health News:Cavidi Signs Agreement With the Clinton Foundation HIV/AIDS Initiative to Lower Costs of HIV Monitoring 2Health News:Cavidi Signs Agreement With the Clinton Foundation HIV/AIDS Initiative to Lower Costs of HIV Monitoring 3Health News:AstraZeneca Receives Six Months Pediatric Exclusivity Patent Extension for ARIMIDEX(R) (anastrozole) from the FDA 2Health News:AstraZeneca Receives Six Months Pediatric Exclusivity Patent Extension for ARIMIDEX(R) (anastrozole) from the FDA 3
The Emit 2000 Phenytoin Assay is a homogeneous enzyme immunoassay intended for use in the quantitative analysis of phenytoin in human serum or plasma. Emit 2000 assays are designed for use with most ...
Our high quality therapeutic drug monitoring reagents, calibrators and controls are available for most chemistry analyzers. Reproducible and accurate results for your laboratory needs....
The Emit 2000 Digoxin Calibrators are intended for use with the Emit 2000 Digoxin Assay....
... The Newmarket Laboratories RPR kits use ... of lipid antigens, which will combine ... or plasma. The particles are suspended ... eliminate non - specific reactions. Positive ...
Medicine Products: